Month: January 2022

Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Fourth Quarter and Fiscal Year Ended December 31, 2021 Financial Results

Written by Customer Service on January 24, 2022. Posted in Public Companies.

LOS ANGELES, Jan. 24, 2022 (GLOBE NEWSWIRE) — Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2021 on Wednesday, February 23, 2022 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Thursday, February 24, 2022 at 12:00 p.m. Eastern Time to discuss its fourth quarter and fiscal year ended December 31, 2021 financial results. Conference Call Information: The conference call will be broadcast live at 12:00 p.m. Eastern Time on the Investor Relations section of Crescent BDC’s website at www.crescentbdc.com. Please visit the website to test your connection before the webcast. Participants are also invited to access the conference call by dialing one of...

Delisting of Securities of iFresh Inc. and Odonate Therapeutics, Inc. from The Nasdaq Stock Market

Written by Customer Service on January 24, 2022. Posted in Public Companies.

NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) — The Nasdaq Stock Market announced today that it will delist the common stock of iFresh Inc. iFresh Inc.’s common stock was suspended on November 23, 2021 and has not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the common stock of Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.’s common stock was suspended on January 18, 2022 and has not traded on Nasdaq since that time. Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delistings. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delisting and whether the companies’ securities are trading on another venue, please review the companies’ public filings or contact...

SmartCentres Declares Distribution for January 2022

Written by Customer Service on January 24, 2022. Posted in Dividend Reports And Estimates.

TORONTO, Jan. 24, 2022 (GLOBE NEWSWIRE) — SmartCentres Real Estate Investment Trust (“SmartCentres” or the “Trust”) (TSX:SRU.UN) announced today that the trustees of SmartCentres have declared a distribution for the month of January 2022 of CDN $0.15417 per trust unit, representing CDN $1.85 per unit on an annualized basis. Payment will be made on February 15, 2022 to unitholders of record on January 31, 2022. About SmartCentres SmartCentres Real Estate Investment Trust is one of Canada’s largest fully integrated REITs, with a best-in-class portfolio featuring 168 strategically located properties in communities across the country. SmartCentres has approximately $10.2 billion in assets and owns 33.9 million square feet of income producing value-oriented retail space with 97.6% occupancy, on 3,500 acres of owned land across Canada. SmartCentres...

Ninepoint Partners Announces January 2022 Cash Distributions for ETF Series Securities

Written by Customer Service on January 24, 2022. Posted in Dividend Reports And Estimates.

TORONTO, Jan. 24, 2022 (GLOBE NEWSWIRE) — Ninepoint Partners LP (“Ninepoint Partners”) today announced the January 2022 cash distributions for its ETF Series securities. The record date for the distributions is January 31, 2022 for Ninepoint High Interest Savings Fund and February 1, 2022 for Ninepoint Diversified Bond Fund and Ninepoint Alternative Credit Opportunities Fund. All distributions are payable on February 8, 2022. The per-unit January distributions are detailed below:Ninepoint ETF Series Ticker Distribution per unit Notional Distributionper unit CUSIPNinepoint Diversified Bond Fund NBND $0.03121 $0.00000 65443H100Ninepoint High Interest Savings Fund NSAV $0.02886 $0.00000 65443X105Ninepoint Alternative Credit Opportunities Fund NACO $0.06469 $0.00000 65443Q100About Ninepoint Partners Based in Toronto,...

StorageVault Completes the Purchase of Storage Asset for $45 Million

Written by Customer Service on January 24, 2022. Posted in Mergers And Acquisitions.

TORONTO, Jan. 24, 2022 (GLOBE NEWSWIRE) — STORAGEVAULT CANADA INC. (“StorageVault”) (SVI-TSX-V) is pleased to announce that, further to its January 18, 2022 news release, it has completed the acquisition of one store in Toronto, Ontario (the “Acquisition”) for $45,000,000. The Acquisition is a related party acquisition as Access Self Storage Inc. (“Access”) was one of the vendors in the Acquisition. The purchase price for the Acquisition in the amount of $45,000,000, subject to customary adjustments, was paid by the issuance of 3,356,560 common shares of StorageVault (the “Payment Shares”) to the vendors at an aggregate purchase price of $22,000,000, with the remainder of the purchase price being paid with funds on hand or consisting of debt of the store being acquired. The Payment Shares are subject to a hold period that expires...

Glatfelter Corporation to Report Earnings on February 10th

Written by Customer Service on January 24, 2022. Posted in Public Companies.

CHARLOTTE, N.C., Jan. 24, 2022 (GLOBE NEWSWIRE) — Glatfelter Corporation (NYSE: GLT), announced today that it expects to issue its 2021 fourth-quarter results on Thursday, February 10, 2022. Management will hold a conference call at 11:00 AM (ET) that morning to discuss the Company’s results. Glatfelter’s earnings release and an accompanying financial supplement, which includes significant financial information to be discussed on the conference call, will be available on its Investor Relations website at https://www.glatfelter.com/investors/.What: Glatfelter Corporation’s 4th Quarter 2021 Earnings Release Conference Call When: Thursday, February 10, 2022 11:00 a.m. (ET) Number: US dial (888) 335-5539 International dial (973) 582-2857 Conference ID: 5347333 Webcast: https://www.glatfelter.com/investors/webcasts-and-presentations/ Rebroadcast...

PCI Biotech: Update on the RELEASE trial

Written by Customer Service on January 24, 2022. Posted in Public Companies.

Oslo (Norway), 24 January 2022 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that the company has decided to stop the RELEASE study and focus their drug development efforts on the promising immunotherapy opportunities with both fimaVacc and fimaNAc assets. The decision to stop the RELEASE study is based on recent randomised Phase III clinical trial results presented at the American Society of Clinical Oncology Gastrointestinal Cancer Symposium (ASCO GI, January 20-22, 2022) from the TOPAZ-1 study, demonstrating that a combination of immune checkpoint inhibition with gemcitabine and cisplatin provides a significant survival benefit to patients with advanced biliary tract cancer compared with placebo plus gemcitabine and cisplatin. These results are expected to rapidly change the first line standard...

ITA Airways received an Expression of Interest from MSC and Lufthansa

Written by Customer Service on January 24, 2022. Posted in Mergers And Acquisitions.

ITA Airways received an Expression of Interest from MSC and LufthansaITA Airways received an Expression of Interest from MSC and Lufthansa. Rome, 24 January 2022 – The Company announces that today it has received an Expression of Interest from the MSC Group and Lufthansa to acquire the majority of ITA Airways. The MSC Group has agreed with Lufthansa its participation in the partnership on terms to be defined during the Due Diligence.ROME, Jan. 24, 2022 (GLOBE NEWSWIRE) — The Company announces that today it has received an Expression of Interest from the MSC Group and Lufthansa to acquire the majority of ITA Airways. The MSC Group has agreed with Lufthansa its participation in the partnership on terms to be defined during the Due Diligence. Both the MSC Group and Lufthansa have expressed the wish that the...

iCAD’s Breast AI Platform Earns U.S. Department of Defense Authorization to Operate

Written by Customer Service on January 24, 2022. Posted in Public Companies.

Leading-edge breast cancer detection platform meets stringent U.S. government security thresholds required for use across military healthcare facilities NASHUA, N.H., Jan. 24, 2022 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that the Company’s breast artificial intelligence (AI) platform was granted an Authorization to Operate (ATO) from the U.S. Department of Defense (DoD). iCAD’s breast AI platform includes ProFound AI®, which became the first AI software for digital breast tomosynthesis (DBT) to be FDA cleared in 2018. “It is a significant accomplishment for our technology to achieve this authorization,” said Stacey Stevens, President and incoming Chief Executive Officer of iCAD, Inc. “This distinction is a testament...

World Insurance Associates Acquires Steve Love Insurance Agency

Written by Customer Service on January 24, 2022. Posted in Mergers And Acquisitions.

Tinton Falls, NJ, Jan. 24, 2022 (GLOBE NEWSWIRE) — World Insurance Associates LLC (“WIA”), a Top 100 Insurance Brokerage, announced today that it acquired Steve Love Insurance Agency (“Steve Love”) of Virginia Beach, VA on December 31, 2021. Terms of the transaction were not disclosed. Steve Love Insurance Agency provides personal insurance, including car, home, and life, as well as business insurance. “We have a down-to-earth, personal approach to service and offer individual solutions to our clients,” says Steve Love, Owner, Steve Love Insurance Agency. ”Our team is focused and we work hard to earn the privilege of providing for our clients’ needs. We are happy to continue to do so as part of WIA.” “I’m happy to welcome Steve Love to the World family,” says Rich Eknoian, CEO and Co-Founder of WIA. “Their motto is “Dedicated...

Month: January 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals